SunCar Technology Group Inc. (the “Company” or “SunCar”) (NASDAQ: SDA), a leader in digitalizing auto insurance and auto services, has signed an AI technology cooperation agreement with Volcano Engine, ByteDance's enterprise technology service platform, integrating ByteDance's Doubao Large Language Model (“LLM”) into the Company's core services. This collaboration marks a critical milestone in the Company's […]

New U.S. data will offer first-of-its-kind evidence in patients with kidney failure DaVita today announced the launch of two groundbreaking initiatives aimed to deepen the medical community's understanding of middle-molecule removal and its potential to improve outcomes for patients with kidney failure. Research shows that when waste particles with larger molecular weight build up in

Acquisition strengthens Canadian company's end-to-end forestry planning, operations, and sustainability solutions October 20, 2025 -Remsoft, a global leader in Forest Intelligence solutions, has acquired LOGR, an Australian forestry technology company known for its innovative real-time data capture and operational multi-party analytics platform. The acquisition advances Remsoft's strategy to build a unified, cloud-based ecosystem that connects

Founder Jeff Molloy urges reform as insurance leaders gather at HLTH 2025: “ShopADoc.comdoesn't replace insurance-it redefines how dental affordability works.” As HLTH 2025 opens in Las Vegas, the discussion of health-benefit sustainability now extends to dental care. With premiums projected to rise again in 2026 and the federal budget stretched by subsidy extensions, industry observers

Built around a 'performance flywheel' concept, it supports performance in motion Workleap, a leading Canadian software company building the AI-powered talent management platform teams actually love to use, announces several new features for Workleap Performance that enable a more connected workflow through its signature performance flywheel. The update gives HR and managers a simple, collaborative

Transaction Expands Company's Footprint into Daytona Beach and Florida's East Coast Construction Partners, Inc. (NASDAQ: ROAD) (“CPI” or the “Company”), a vertically integrated civil infrastructure company specializing in the construction and maintenance of roadways in local markets across the Sunbelt, today announced that it has acquired P&S Paving, Inc. (“P&S”), headquartered in Daytona Beach, Florida.

The viral Amazon bedding brand is celebrating a decade of cozy moments, real stories, and GentleSoft® innovation Bedsure, one of the fastest-growing home textile brands on Amazon, is celebrating its 10th anniversary with the launch of their “100SoftHomes – Live Soft, Feel GentleSoft®” campaign. https://mma.prnewswire.com/media/2800166/20251020_140637.jpg This nationwide campaign honors the authentic, everyday moments that define

Earnings Call Scheduled for 8:30 p.m. ETonNovember 4,2025 Zepp Health Corporation (“Zepp Health” or the “Company”) (NYSE: ZEPP), a global leader in smart wearables and health technology,today announced that it will reportits third quarter 2025 unaudited financial results after the market close on Tuesday, November 4, 2025. Management will hold a conference call at 8:30

Solve Industrial Motion Group has acquired B&B Manufacturing, a domestic manufacturer of power transmission and precision mechanical components. Solve Industrial Motion Group (“Solve”), a leading provider of engineered bearings and power transmission solutions, has today announced its acquisition of B&B Manufacturing, (“B&B”) a US manufacturer of power transmission and precision mechanical components. https://mma.prnewswire.com/media/2799505/Solve_Industrial_Motion_Logo.jpg B&B, in

— Upadacitinib demonstrated superiority versus adalimumab forprimary endpoint of achieving low disease activity (DAS28-CRP≤3.2) and ranked secondary endpoint of remission(DAS28-CRP<2.6) at week 121 — SELECT-SWITCH is the firstPhase 3b/4 head-to-head trial comparing TNF inhibitor cycling with switching to upadacitinib in adults with moderate to severe rheumatoid arthritis and inadequate response or intolerance to a TNF